SCHEMBL13459534

SCHEMBL13459534

N#Cc1nccc2c(-c3ccc(N)cc3)cccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLG P00747 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ ALOX15 P16050 2/20 0.38
▸ SQOR Q9Y6N5 1/20 0.38
▸ PRKCZ Q05513 1/20 0.37
▸ FYN P06241 1/20 0.37
▸ CACNA2D1 P54289 2/20 0.37
▸ GSK3B P49841 2/20 0.36
▸ DYRK1A Q13627 2/20 0.36
▸ KDR P35968 3/20 0.36
▸ KIT P10721 2/20 0.36
▸ FLT3 P36888 2/20 0.36
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29072312 0.83 ALDH1A1 (0.40) PLGKDM4EALDH1A1POLBALOX15
SCHEMBL28674762 0.81 ENPP2 (0.39) PLGKDM4EALDH1A1POLBALOX15
SCHEMBL3939571 0.78 ALDH1A1 (0.48) KDM4EALDH1A1POLBALOX15CACNA2D1
SCHEMBL4511200 0.78 TGFBR1 (0.50) PLGPRKCZKDRKITFLT3
SCHEMBL30506029 0.77 CACNA2D1 (0.35) PLGKDM4EALDH1A1POLBFYN
SCHEMBL4856952 0.71 PLAU (0.46) KDM4EALDH1A1POLBALOX15CACNA2D1
SCHEMBL28683978 0.71 KDM4E (0.62) KDM4EALDH1A1POLBALOX15CACNA2D1
SCHEMBL20292623 0.71 KDM4E (0.44) KDM4EALDH1A1POLBALOX15CACNA2D1
SCHEMBL7438690 0.71 KDM4E (0.44) KDM4EALDH1A1POLBALOX15CACNA2D1
SCHEMBL13723931 0.71 CYP1A2 (0.48) KDM4EALDH1A1POLBALOX15CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback